U.S. Banks Stock News

NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

Viatris (VTRS) Could Be 59% Undervalued As Cash Flow And Pipeline Draw Focus

Recent analyst coverage has put Viatris (VTRS) in the spotlight as a value stock, with attention on its cash generation, late stage pipeline, and recent fixed income offerings that add another layer to the investment story. See our latest analysis for Viatris. Viatris has seen momentum build over 2026, with a 27.85% year to date share price return and a 22.07% 90 day share price return. The 1 year total shareholder return of 81.56% reflects how recent fixed income offerings and pipeline...
NYSE:SPXC
NYSE:SPXCMachinery

Should SPX Technologies’ (SPXC) Leadership Shift and Analyst Upgrade Reshape Its Management Quality Narrative?

SPX Technologies recently announced a planned leadership transition in its Detection & Measurement segment, with long-time executive John Swann set to retire in January 2027 and Eric Kaled assuming segment leadership from August 31, 2026, while Swann stays through year-end to support key initiatives. The move comes as analysts have become more positive on SPX Technologies’ earnings outlook, with an upgraded Zacks Rank suggesting growing confidence in its near-term performance. We’ll explore...
NasdaqGS:MANH
NasdaqGS:MANHSoftware

Manhattan’s New AI‑Enabled Marketplace Might Change The Case For Investing In Manhattan Associates (MANH)

Earlier this week, Manhattan Associates introduced Manhattan Marketplace, a major addition to its ActivePlatform that lets customers and partners discover, deploy, and build intelligent agents, extensions, and accelerators directly within its supply chain ecosystem. This move materially advances Manhattan Associates’ push toward an open, AI‑enabled platform where third parties can plug in interoperable solutions without complex integration work. Next, we’ll examine how this expansion of...
NasdaqGS:MLKN
NasdaqGS:MLKNCommercial Services

Is MillerKnoll (MLKN) Undervalued Following Its Earnings Beat And 2027 Growth Guidance?

MillerKnoll (MLKN) stock was in focus after the company paired its fourth quarter and full year 2026 earnings release with fresh fiscal 2027 guidance, combining an earnings and revenue beat with projected sales growth. See our latest analysis for MillerKnoll. The stronger than expected earnings and guidance helped push MillerKnoll’s 1 day share price return to 7.35%, extending a recent run that includes a 14.70% 90 day share price return. The 3 year total shareholder return of 33.26%...
NasdaqGS:NDAQ
NasdaqGS:NDAQCapital Markets

Nasdaq (NDAQ) Faces A Valuation Test, Is The 23% Undervalued View Convincing?

Nasdaq (NDAQ) has recently drawn attention after a period in which the stock declined about 10% over the past month and roughly 3% over the past 3 months, prompting renewed focus on its fundamentals. See our latest analysis for Nasdaq. At a share price of $81.61, Nasdaq has seen its short term share price momentum cool, with the 30 day share price return down 10.33% and the year to date share price return down 15.57%. In contrast, the 3 year total shareholder return of 71.54% and 5 year total...
NasdaqGS:COIN
NasdaqGS:COINCapital Markets

Coinbase (COIN) Opens EU MiCA Hub As Binance Leaves Greece

Coinbase Global (NasdaqGS:COIN) has opened its Luxembourg MiCA hub to all 27 EU states as new digital asset rules draw closer. Rival exchange Binance is exiting the Greek market ahead of those same regulatory deadlines. In the U.S., Coinbase is backing the upcoming CLARITY Act hearing scheduled for July, which could reshape digital asset oversight. Coinbase Global, best known for its crypto trading platform and related services, now sits at the center of two important regulatory storylines...
NYSE:MCO
NYSE:MCOCapital Markets

How Moody’s Open, Platform-Agnostic AI Skills and MCP Integrations Will Impact Moody's (MCO) Investors

In June 2026, Moody’s Corporation released its first set of open, platform-agnostic AI skills and connected its decision-grade intelligence to Model Context Protocol servers, enabling complex workflows like earnings call summaries, peer analysis, and sector analysis to run directly inside tools such as Microsoft 365 Copilot Cowork. By encoding its proprietary analytical frameworks into portable SKILL.md files and MCP integrations, including access through Amazon Quick to data on more than...
NasdaqGS:ULCC
NasdaqGS:ULCCAirlines

Frontier Group Holdings (ULCC) Could Be 52% Overvalued Following The Airline Rally

Frontier Group Holdings (ULCC) is in focus after a sector wide move in US airline stocks following a pullback in crude prices, while a separate boardroom change adds a governance angle for investors to assess. See our latest analysis for Frontier Group Holdings. Against this backdrop, Frontier Group Holdings has seen a sharp shift in sentiment, with a 39.92% 1 month share price return, a 110.48% 3 month share price return and a 105.82% 1 year total shareholder return, even though the 3 year...
NasdaqCM:PLUG
NasdaqCM:PLUGElectrical

Plug Power (PLUG) Lands A 5 MW Denmark Electrolyzer Milestone In Green Hydrogen

Plug Power has completed installation, commissioning, and handover of a 5 MW GenEco PEM electrolyzer in Esbjerg, Denmark. The unit is now operating at European Energy's Måde Power-to-X facility as one of Denmark's early commercial-scale green hydrogen projects. This marks a commercial reference for Plug Power's electrolyzer technology in a European utility-scale setting. For investors tracking Plug Power, NasdaqCM:PLUG, this project gives fresh context to a stock that has seen sharp swings...
NasdaqGS:SDGR
NasdaqGS:SDGRHealthcare Services

Schrödinger (SDGR) Maintains Guidance And Expands AI Push, Is It Still Below Fair Value?

Schrödinger (SDGR) has been back in focus after shareholders approved an amendment to the 2022 Equity Incentive Plan and the company reiterated guidance tied to its hosted software transition and emerging AI co scientist, Bunsen. See our latest analysis for Schrödinger. Those governance decisions and the rollout of Schrödinger’s hosted software and AI co scientist arrive after a 90 day share price return of 38.36%, alongside a 1 year total shareholder return decline of 25.18% and a 5 year...
NYSE:FUL
NYSE:FULChemicals

Is H.B. Fuller (FUL) Below Fair Value Or Is Its Growth Already Priced In?

H.B. Fuller (FUL) has drawn fresh attention after recent share price moves, with the stock closing at US$64.60. That level, combined with its latest financial profile, is prompting closer scrutiny from income and quality focused investors. See our latest analysis for H.B. Fuller. Recent trading has been mixed for H.B. Fuller, with a 2.34% 1 day share price return contrasting with a 7.06% year to date share price return and a 17.27% 1 year total shareholder return. This hints that longer term...
NasdaqGS:RUSH.A
NasdaqGS:RUSH.ATrade Distributors

Is Rush’s Canadian Credit Expansion and New COO Altering The Investment Case For Rush Enterprises (RUSH.A)?

Rush Enterprises recently amended its financing agreement with Bank of Montreal to increase the loan commitment for its Canadian subsidiary, Rush Truck Centres of Canada Limited, and announced that Jody Pollard has taken over as chief operating officer from Jason Wilder. Together, the expanded credit support for the Canadian business and a new COO signal an operational refresh that could influence how Rush allocates capital and manages growth initiatives across its dealership network. Next,...
NYSE:USB
NYSE:USBBanks

U.S. Bancorp (USB) Gets Capital Clarity On Dividend Plans While Valuation Questions Linger

U.S. Bancorp (USB) highlighted that the Federal Reserve will keep its 2.6% stress capital buffer unchanged until 2027. The company now plans a 3.8% quarterly dividend increase, pending board approval. See our latest analysis for U.S. Bancorp. Recent news around the stable 2.6% stress capital buffer and the planned dividend increase comes on top of a strong run in the stock, with U.S. Bancorp’s 30 day share price return of 9.63% and 90 day share price return of 16.51% feeding into a 1 year...
NasdaqGS:NTRA
NasdaqGS:NTRABiotechs

US Stock Market Today: S&P 500 Futures Edge Up As Traders Eye PCE Inflation

The Morning Bull - US Market Morning Update Thursday, Jun, 25 2026 US stock futures are pointing slightly higher this morning, with E-mini S&P 500 contracts up about 0.1% and Nasdaq-100 futures ahead roughly 0.5%, as investors juggle three main forces. First, US manufacturing is showing fresh strength, with the manufacturing PMI at 55.7 and the composite PMI at 52.2, which signals business activity is growing even as job numbers in these surveys soften. Second, progress in US Iran talks is...
NYSE:VMI
NYSE:VMIConstruction

Can Valmont Industries (VMI) Justify Its Valuation On New 2029 Guidance?

Valmont Industries (VMI) issued fresh 2029 earnings guidance, projecting a 17% operating margin and EPS of $35. This update gives investors a longer term view on profitability expectations and potential implications for the stock. See our latest analysis for Valmont Industries. Valmont Industries’ guidance lands after a strong run, with a 30 day share price return of 9.73% and a 90 day share price return of 41.09%, while the 1 year total shareholder return of 74.65% points to momentum that...
NYSE:REVG
NYSE:REVGMachinery

Defence Stocks Investors May Want To Screen As Europe Reworks Funding

The proposed Defence, Security and Resilience Bank could reshape how capital flows into defence and aerospace, with more than €850b in annual spending across Europe and Canada and targeted support for supply chains and smaller contractors. For investors, this raises a practical question: which stocks might benefit most from easier access to financing and potentially larger order pipelines, and which might not? This article focuses on large, established defence and aerospace companies exposed...
NasdaqGM:HROW
NasdaqGM:HROWPharmaceuticals

How Grow Funds’ Exit and Weaker Earnings Recast Harrow’s (HROW) Growth Narrative and Governance Choices

Harrow, Inc. recently held its 2026 Annual Meeting of Stockholders, where all director nominees and executive compensation were approved and Deloitte & Touche LLP was ratified as auditor. A separate update from Grow Funds drew attention to Harrow’s disappointing earnings and a slight reduction in hedge fund ownership, highlighting tension between prior growth expectations and actual performance. We’ll now examine how Grow Funds’ decision to exit its position and flag weaker earnings shapes...
NYSE:DPC
NYSE:DPCAerospace & Defense

DPC Holdings (DPC) Looks Undervalued As Losses Test The Revenue Growth Story

How DPC Holdings Stock Looks Today DPC Holdings (DPC) currently trades at $30.00, valuing the aerospace focused manufacturer at about $4.2b, with reported revenue of $886.0 and a net loss of $167.0 in its latest figures. For investors tracking value indicators, the stock carries an intrinsic discount measure of 0.19595 and a value score of 3, while short term performance data is limited and the 1 day move is flat at 0.0%. See our latest analysis for DPC Holdings. With a year to date share...
NYSE:OMF
NYSE:OMFConsumer Finance

OneMain Holdings (OMF) Looks Undervalued On Paper, Is The Legal Risk Already Priced In?

Recent Performance Context for OneMain Holdings OneMain Holdings (OMF) stock has gained around 0.9% over the past day and about 1.7% over the past week, while its month and past 3 months returns sit near 9.5% and 10.4%. See our latest analysis for OneMain Holdings. That recent 1 month share price return of 9.5% compares with a year-to-date share price decline of about 15.2%, while longer-term total shareholder returns of 13.5% over 1 year and 73.1% over 3 years show how sentiment around...
NYSE:TDC
NYSE:TDCSoftware

Teradata (TDC) Could Be 5% Undervalued After Cloud Growth And Earnings Optimism

Teradata stock reacts to cloud momentum and earnings optimism Teradata (TDC) shares recently moved higher after a 5% gain on strong volume, as investors focused on improving cloud growth, rising earnings estimates, and expanding VantageCloud partnerships with major hyperscale providers. See our latest analysis for Teradata. Teradata’s recent 5% jump sits against a mixed backdrop, with the share price up 20.82% over 90 days and 6.74% year to date, while the 1 year total shareholder return of...
NYSE:STZ
NYSE:STZBeverage

The Bull Case For Constellation Brands (STZ) Could Change Following Q1 FY27 Earnings Surprise Shift In Focus

Constellation Brands recently released its first‑quarter fiscal 2027 results on June 30, 2026, with analysts previously expecting earnings growth despite softer revenue. The key twist is that analyst sentiment had turned more cautious on near‑term earnings heading into the report, sharpening investor focus on how the company is managing profit drivers versus top‑line pressure. We’ll now examine how this shift in analyst expectations for earnings ahead of the June 30 report shapes...
NYSE:GE
NYSE:GEAerospace & Defense

Is General Electric (GE) Fairly Valued After Strong Order Growth And A Better Outlook?

General Electric (GE) is back in focus after the board elected Microsoft executive Judson Althoff as an independent director, coinciding with stronger shareholder returns, order momentum in defense and electrification, and a supportive earnings outlook. See our latest analysis for General Electric. At a share price of US$365.88, General Electric has built strong momentum, with a 20.82% 1 month share price return and a 47.19% 1 year total shareholder return. The 5 year total shareholder return...
NYSE:FAF
NYSE:FAFInsurance

Should FAF’s Defense of Traditional Title Insurance Amid Reform Debate Require Action From Investors?

In June 2026, First American Financial published a white paper underscoring how title insurance underpins the U.S. property rights system and real estate infrastructure by mitigating title defects and preserving reliable ownership records. The analysis warns that proposals to waive or replace title insurance could shift risk onto homeowners, lenders, investors, and taxpayers, potentially weakening property record quality and the resilience of the broader real estate ecosystem. We’ll now...
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

Does STELLAR-303’s Mixed Survival Signal Reshape the Bull Case for Exelixis’ Pipeline Strategy (EXEL)?

Exelixis recently reported final overall survival results from the phase 3 STELLAR-303 trial, showing a non-statistically significant trend favoring zanzalintinib plus atezolizumab over regorafenib in metastatic colorectal cancer patients without active liver metastases, with no new safety issues identified. Although the non-liver metastases subgroup missed statistical significance, these data sit alongside previously published overall survival benefit in the full trial population and an...